Explore more publications!
Healthcare Journal of Oregon
Got News to Share?

Healthcare Journal of Oregon: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Journal of Oregon.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 17, 2026

Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital
Apr. 17, 2026

Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital

Indeterminate GlobeNewswire
SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson
Apr. 17, 2026

SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson

Indeterminate GlobeNewswire
First Steps Developmental Services Expands Services in Woburn
Apr. 17, 2026

First Steps Developmental Services Expands Services in Woburn

Indeterminate GlobeNewswire
Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting
Apr. 17, 2026

Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting

Indeterminate GlobeNewswire
Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
Apr. 17, 2026

Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026

Indeterminate GlobeNewswire
Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC
Apr. 17, 2026

Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC

Indeterminate GlobeNewswire
Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome
Apr. 17, 2026

Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome

Indeterminate GlobeNewswire
Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network
Apr. 17, 2026

Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network

Indeterminate GlobeNewswire
Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors
Apr. 17, 2026

Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors

Indeterminate GlobeNewswire
BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting
Apr. 17, 2026

BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting

Indeterminate GlobeNewswire
Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
Apr. 17, 2026

Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference

Indeterminate GlobeNewswire
Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006 in Hepatic Encephalopathy
Apr. 17, 2026

Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006 in Hepatic Encephalopathy

Indeterminate GlobeNewswire
Invest in the Future of Clean Energy Drinks: US Capital Global Securities Announces $10 Million Offering for G.O.A.T. Fuel
Apr. 17, 2026

Invest in the Future of Clean Energy Drinks: US Capital Global Securities Announces $10 Million Offering for G.O.A.T. Fuel

Indeterminate GlobeNewswire
Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib
Apr. 17, 2026

Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib

Indeterminate GlobeNewswire
Immuron Double Digit 3Q Sales Growth
Apr. 17, 2026

Immuron Double Digit 3Q Sales Growth

Indeterminate GlobeNewswire
New Nordic white paper reveals systemic barriers preventing women from reaching leadership roles
Apr. 17, 2026

New Nordic white paper reveals systemic barriers preventing women from reaching leadership roles

Indeterminate GlobeNewswire
Bioxodes expands Clinical Advisory Board, shares pivotal trial design for BIOX-101 in intracerebral hemorrhage
Apr. 17, 2026

Bioxodes expands Clinical Advisory Board, shares pivotal trial design for BIOX-101 in intracerebral hemorrhage

Indeterminate GlobeNewswire
Carbios announces fiscal-year 2025 financial results
Apr. 17, 2026

Carbios announces fiscal-year 2025 financial results

Indeterminate GlobeNewswire
CARBIOS présente ses résultats annuels 2025
Apr. 17, 2026

CARBIOS présente ses résultats annuels 2025

Indeterminate GlobeNewswire
Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock
Apr. 17, 2026

Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions